ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1782.5

Monocytes from HLA B27 Positive Enthesitis Related Arthritis Patients Are More Activated Than HLA B27 Negative Patients

Shivika Guleria1, Anu Balakrishnan1, Able Lawrence1 and Amita Aggarwal2, 1SGPGIMS, Lucknow, Lucknow, Uttar Pradesh, India, 2Sanjay Gandhi Postgraduate Institute of Medical Sciences, Lucknow, India, Lucknow, Uttar Pradesh, India

Meeting: ACR Convergence 2024

Keywords: cytokines, Juvenile idiopathic arthritis, Monocytes/macrophages

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Monday, November 18, 2024

Title: Pediatric Rheumatology – Basic Science Poster

Session Type: Poster Session C

Session Time: 10:30AM-12:30PM

Background/Purpose: Enthesitis related arthritis (ERA) is a chronic immune-inflammatory disease with unknown etiology. HLA-B27 is the strongest risk factor predisposing to ERA similar to Spondylarthritis (SpA). Children with HLA-B27 have a more severe disease course and are more likely to have uveitis and sacroiliitis.  In adult SpA, HLA-B27 has been associated with defective bacterial handling, UPR and inflammasome activation in monocytes.  However, no data is available in ERA thus, we studied monocytes in patients with ERA.

Methods: Patients with ERA (ILAR classification) and healthy controls (HCs) were enrolled in the study after informed consent. HLA-B27 was done by PCR. Using flow cytometry monocytes subsets were studied using anti-CD14 and anti-CD16 antibodies, superoxide (ROS) production was measured by Dihydrorhodamine 123 assay while Phagocytosis was measured using pH rhodo Green E. coli Bioparticle Conjugate. Cytokine production by the monocytes after LPS (10ng/ml) stimulation was measured by ELISA.  

Results: 60 HLA-B27 positive, 13 HLA-B27 negative and 19 HLA-B27 negative HCs were included. Clinical features were similar in both HLA-B27 positive and negative ERA patients except the family history which was only present in HLA-B27 positive patients (p< 0.05). JSpADA Score and ESR were higher in HLA-B27 positive patients compared to B27 negative patients (Table 1).

The frequency of Classical Monocytes was higher in B27 positive patients compared to B27 negative patients and B27 negative HCs (p< 0.05; Figure 1a). Monocytes of B27 positive patients produced more superoxide compared to B27 negative HCs (7.180 vs 2.965, p< 0.0001; Figure 1b). Phagocytic Index was higher in B27 positive patients compared to B27 negative patients and HCs (3.390 vs 1.70, p< 0.05; 3.39 vs 1.72, p< 0.05; Figure 1c). TNF- α production was higher at baseline in B27 positive patients compared to B27 negative patients and also on LPS stimulation (8.22 pg/ml vs 0.4035 pg/ml, p< 0.05; 993.7pg/ml vs 343.4pg/ml, p< 0.01; Fig 1d). IL-6 production showed a trend towards increased production in B27 positive patients compared to B27 negative patients.

Conclusion: HLA B27 positive patient’s monocytes were more pro-inflammatory with higher ROS production, increased phagocytosis, and TNF– α production thus may result in persistent inflammation and more severe disease in HLA B27 group.

Supporting image 1

Clinical Characteristics and demographic details of the JIA-ERA patients

Supporting image 2

1. (a) Frequency of Classical Monocytes (b) Monocytic oxidative Index (c) Phagocytic Index (d) TNF- α production (ng/ml) at baseline by monocytes in B27 positive JIA-ERA patients, B27 negative JIA-ERA patients and HCs (* p<0.05, **** p<0.0001)


Disclosures: S. Guleria: None; A. Balakrishnan: None; A. Lawrence: None; A. Aggarwal: None.

To cite this abstract in AMA style:

Guleria S, Balakrishnan A, Lawrence A, Aggarwal A. Monocytes from HLA B27 Positive Enthesitis Related Arthritis Patients Are More Activated Than HLA B27 Negative Patients [abstract]. Arthritis Rheumatol. 2024; 76 (suppl 9). https://acrabstracts.org/abstract/monocytes-from-hla-b27-positive-enthesitis-related-arthritis-patients-are-more-activated-than-hla-b27-negative-patients/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2024

ACR Meeting Abstracts - https://acrabstracts.org/abstract/monocytes-from-hla-b27-positive-enthesitis-related-arthritis-patients-are-more-activated-than-hla-b27-negative-patients/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology